ENDOCARE INC Uncategorized Contracts & Agreements
57 Contracts & Agreements
- Exhibit No (Filed With SEC on June 9, 2009)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on October 6, 2008)
- High quality of life following treatment. Our minimally invasive procedure typically offers patients a short recovery period for prostate cancer therapy and may result in a lower... (Filed With SEC on March 17, 2008)
- High quality of life following treatment. Our minimally invasive procedure typically offers patients a short recovery period for prostate cancer therapy and may result in a lower... (Filed With SEC on March 17, 2008)
- High quality of life following treatment. Our minimally invasive procedure typically offers patients a short recovery period for prostate cancer therapy and may result in a lower... (Filed With SEC on March 17, 2008)
- Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (Filed With SEC on February 11, 2008)
- Three Months Ended September 30 (Filed With SEC on November 6, 2007)
- SVB waived the Companys noncompliance with the tangible net worth covenant for the months ended September 30, 2006, October 31, 2006 and November 30, 2006 (Filed With SEC on December 22, 2006)
- ENDOCARE, INC (Filed With SEC on December 13, 2006)
- Three Months Ended (Filed With SEC on November 9, 2006)
- Three Months Ended (Filed With SEC on November 9, 2006)
- Three Months Ended (Filed With SEC on August 8, 2006)
- Three Months Ended (Filed With SEC on August 8, 2006)
- Three Months Ended (Filed With SEC on August 8, 2006)
- Description of Salary Adjustments for William J. Nydam and Michael R. Rodriguez, effective January 1, 2006 (Filed With SEC on May 10, 2006)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2006)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2006)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2006)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2006)
- $8,075,000 in cash; and (Filed With SEC on January 18, 2006)
- Effective Date: January 17, 2006 (Filed With SEC on January 12, 2006)
- The annual retainer payable to each of our non-employee directors was increased from $18,000 to $25,000 (Filed With SEC on September 16, 2005)
- The annual retainer payable to each of our non-employee directors was increased from $18,000 to $25,000 (Filed With SEC on September 16, 2005)
- Three Months Ended (Filed With SEC on May 10, 2005)
- Three Months Ended (Filed With SEC on May 10, 2005)
- Three Months Ended (Filed With SEC on May 10, 2005)
- ENDOCARE, INC (Filed With SEC on May 3, 2005)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2005)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2005)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2005)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2005)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2005)
- Non-Cryosurgical Treatment Options (Filed With SEC on March 16, 2005)
- Named Executive Officer (Filed With SEC on March 1, 2005)
- Named Executive Officer (Filed With SEC on March 1, 2005)
- Pro Forma Financial Information (Filed With SEC on January 6, 2005)
- Three Months Ended (Filed With SEC on November 9, 2004)
- Exhibit No (Filed With SEC on September 1, 2004)
- Condensed Consolidated Financial Statements (Filed With SEC on August 9, 2004)
- Three Months Ended March 31 (Filed With SEC on May 10, 2004)
